2025. Single-center, non-randomized, prospective phase II study evaluating the effectiveness of induction chemoimmunotherapy in the combined outcome of locally advanced non-small cell lung disease. Voprosy onkologii. 71, 6 (Dec. 2025), OF-2369. DOI:https://doi.org/10.37469/0507-3758-2025-71-6-OF-2369.